Search For "clinical trial"
First clinical trial of anticancer drug 'CAR-T' is underway for lymphoma p
Updated : 4 years, 4 months ago IST
Seoul [South Korea], October 21 (ANI/Global Economic): An anticancer treatment 'CAR-T (chimeric antigen receptor T-cell),' called a miracle anticancer drug, has been developed and the first clinical trial in Korea is being conducted.
Read More
The Whiteboard announces partnership with Oviya MedSafe for pharmacovigila
Updated : 4 years, 5 months ago IST
Hyderabad (Telangana) [India], October 11 (ANI/NewsVoir): The Whiteboard, a leading academy for training professionals in the field of clinical trials and drug development, announced on Oct 6th, 2021, a partnership with Oviya MedSafe, a global pharmacovigilance consulting and drug safety ser
Read More
18-Month Below-the-Knee data with MedAlliance's SELUTION SLR™ presen
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], October 11 (ANI/PRNewswire): 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21.
Read More
Covid antiviral pill cuts risk of hospitalisation, deaths by half, says ma
Updated : 4 years, 5 months ago IST
Washington [US], October 1 (ANI): An antiviral pill has been found to reduce the risk of hospitalisation and deaths by 50 per cent in patients diagnosed with COVID-19 during clinical trials.
Read More
LTI and eClinicalHealth form strategic partnership to accelerate innovatio
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 28 (ANI/PRNewswire): Larsen & Toubro Infotech (BSE: 540005) (NSE: LTI), a global technology consulting and digital solutions company has entered in a strategic partnership with eClinicalHealth Limited to accelerate digital innovation in R&D Cli
Read More
Adjusting fatty acid intake may help with bipolar disorders
Updated : 4 years, 5 months ago IST
Washington [US], September 25 (ANI): Clinical trial results have shown that a diet designed to alter levels of specific fatty acids consumed by participants may help patients with bipolar disorders have less variability in their mood.
Read More
India tops the chart for approved biosimilars and clinical trials surpassi
Updated : 4 years, 5 months ago IST
Bengaluru (Karnataka) [India], September 24 (ANI/PRNewswire): With an overarching theme of 'Ideate and Innovate' and new prospects of Intellectual Property (IP) in the Indian pharmaceutical industry, Informa Pharma Intelligence, the Knowledge Partner of Pharma IPR 2021, has today concluded t
Read More
MedAlliance announces completion of enrollment in Japanese SELUTION SLR
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], September 23 (ANI/PRNewswire): MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD).
Read More
Patients with high-risk local melanomas benefit from immunotherapy drug: S
Updated : 4 years, 5 months ago IST
Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Read More
Limiting screen time after concussion shortens duration of symptoms
Updated : 4 years, 6 months ago IST
Washington [US], September 11 (ANI): A clinical trial of 125 young adults has shown that those who limited screen time for 48 hours immediately after suffering a concussion had a significantly shorter duration of symptoms than those who were permitted screen time.
Read More
AIIMS Delhi to conduct Phase 2/3 clinical trials of Bharat Biotech's nasal
Updated : 4 years, 6 months ago IST
New Delhi [India], September 8 (ANI): The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday.
Read More
Biological E gets drug regulator's approval to conduct phase 2/3 trials on
Updated : 4 years, 6 months ago IST
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain
Read More